Oncoheroes Biosciences 9/3/24 Oncoheroes Biosciences 9/3/24 Oncoheroes Obtains Exclusive Worldwide Oncology Pediatric Rights Of Dovitinib Read More Oncoheroes Biosciences 9/22/22 Oncoheroes Biosciences 9/22/22 FDA Grants Rare Pediatric Disease Designation (RPDD) to dovitinib for osteosarcoma Read More
Oncoheroes Biosciences 9/3/24 Oncoheroes Biosciences 9/3/24 Oncoheroes Obtains Exclusive Worldwide Oncology Pediatric Rights Of Dovitinib Read More
Oncoheroes Biosciences 9/22/22 Oncoheroes Biosciences 9/22/22 FDA Grants Rare Pediatric Disease Designation (RPDD) to dovitinib for osteosarcoma Read More
